Molecular modeling study on potent and selective adenosine A(3) receptor agonists

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Computational Biology

Background:

• The adenosine A(3) receptor (A(3)AR) plays a crucial role in various physiological and pathological processes.
• A(3)AR agonists are investigated for treating conditions like rheumatoid arthritis, dry eye, asthma, inflammation, and cancer.

Purpose of the Study:

• To rationalize the high affinity and selectivity of novel MECA derivatives for the human A(3)AR.
• To understand the structure-activity relationships of these compounds.

Main Methods:

• Utilized adenosine receptor (AR) structural models based on the A(2A)AR crystal structure.
• Performed molecular docking analysis to predict binding affinities and interactions.
• Conducted post-docking analysis to interpret substituent effects.

Main Results:

• Newly developed MECA derivatives exhibit sub-nanomolar affinity and high selectivity for the human A(3)AR.
• These compounds act as full agonists at the A(3)AR.
• Molecular modeling successfully predicted A(3)AR affinity and provided insights into substituent effects.

Conclusions:

• The study provides a rational basis for the potent activity of MECA derivatives at the A(3)AR.
• These findings support the development of these compounds as potential therapeutic agents.
• Computational modeling is a valuable tool for guiding drug design targeting adenosine receptors.